Drugs / Flomoxef
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02302092 | Dec 2015 → Feb 2016 | urinary tract infection | Takeda | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flomoxef | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02302092 ↗ |
| Modality | Small molecule | — CHEMBL15413 ↗ |
| Route | Intravenous | “Flomoxef intravenous infusion” NCT02302092 ↗ |